Search Results - "Gelders, G."

  • Showing 1 - 19 results of 19
Refine Results
  1. 1
  2. 2

    Amylose–lipid complexation: a new fractionation method by Gelders, G.G, Vanderstukken, T.C, Goesaert, H, Delcour, J.A

    Published in Carbohydrate polymers (15-07-2004)
    “…Amylose fractions of different peak Degree of Polymerisation (DP) (DP20, DP60, DP400, DP950) were complexed with docosanoic acid (C22) and glyceryl…”
    Get full text
    Journal Article
  3. 3

    Enzyme and acid resistance of amylose-lipid complexes differing in amylose chain length, lipid and complexation temperature by Gelders, Greta G., Duyck, Jeroen P., Goesaert, Hans, Delcour, Jan A.

    Published in Carbohydrate polymers (25-05-2005)
    “…To study parameters that influence enzyme and acid resistance of amylose-lipid complexes, complexes were formed between amylose of different average chain…”
    Get full text
    Journal Article
  4. 4

    Amylose−Lipid Complexes as Controlled Lipid Release Agents during Starch Gelatinization and Pasting by Gelders, Greta G, Goesaert, Hans, Delcour, Jan A

    Published in Journal of agricultural and food chemistry (22-02-2006)
    “…The effect of amylose−lipid (AM-L) complexes consisting of amylose populations with different peak degrees of polymerization (DP) and complexed with glyceryl…”
    Get full text
    Journal Article
  5. 5

    Potato Phosphorylase Catalyzed Synthesis of Amylose−Lipid Complexes by Gelders, Greta G, Goesaert, Hans, Delcour, Jan A

    Published in Biomacromolecules (01-09-2005)
    “…On-line size-exclusion chromatography monitoring of potato phosphorylase catalyzed amylose synthesisstarting from α-d-glucose-1-P and maltohexaoserevealed…”
    Get full text
    Journal Article
  6. 6

    Use of Two Endoxylanases with Different Substrate Selectivity for Understanding Arabinoxylan Functionality in Wheat Flour Breadmaking by Courtin, C. M., Gelders, G. G., Delcour, J. A.

    Published in Cereal chemistry (01-09-2001)
    “…ABSTRACT A Bacillus subtilis endoxylanase (XBS) with a strong selectivity for hydrolysis of water‐unextractable arabinoxylan (WU‐AX) and an Aspergillus…”
    Get full text
    Journal Article
  7. 7

    Fractionation of starch hydrolysates into dextrins with narrow molecular mass distribution and their detection by high-performance anion-exchange chromatography with pulsed amperometric detection by Gelders, Greta G, Bijnens, Lieve, Loosveld, Anne-Marie, Vidts, An, Delcour, Jan A

    Published in Journal of Chromatography A (11-04-2003)
    “…Low levels of high-molecular-mass dextrins in starch hydrolysates can be detected by high-performance anion-exchange chromatography with pulsed amperometric…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Effect of serotonin antagonism in schizophrenia: a pilot study with setoperone by CEULEMANS, D. L. S, GELDERS, Y. G, HOPPENBROUWERS, M.-L. J. A, REYNTJENS, A. J. M, JANSSEN, P. A. J

    Published in Psychopharmacologia (01-01-1985)
    “…The new antipsychotic drug setoperone is pharmacologically characterized by its potent serotonin and moderate dopamine receptor blocking properties. Forty…”
    Get full text
    Journal Article
  10. 10

    Pilot clinical investigation of risperidone in the treatment of psychotic patients by Gelders, Y G, Heylen, S L, Vanden Bussche, G, Reyntjens, A J, Janssen, P A

    Published in Pharmacopsychiatry (01-09-1990)
    “…Sixty-one adult psychotic patients were treated for four weeks in an open dose-finding study with the new combined serotonin-dopamine antagonist risperidone (R…”
    Get more information
    Journal Article
  11. 11

    The efficacy of the D2 and 5-HT2 antagonist risperidone (R 64,766) in the treatment of chronic psychosis. An open dose-finding study by Castelão, J F, Ferreira, L, Gelders, Y G, Heylen, S L

    Published in Schizophrenia research (01-07-1989)
    “…After a wash-out period of 1 week, 20 patients suffering from schizophrenia were treated for 4 weeks in an open dose-finding study with a new…”
    Get more information
    Journal Article
  12. 12

    The influence of ritanserin, a serotonin antagonist, in anxiety disorders: a double-blind placebo-controlled study versus lorazepam by Ceulemans, D L, Hoppenbrouwers, M L, Gelders, Y G, Reyntjens, A J

    Published in Pharmacopsychiatry (01-09-1985)
    “…A double-blind study was performed in 83 patients with generalized anxiety disorder comparing daily doses of 5 and 10 mg ritanserin (a selective antagonist of…”
    Get more information
    Journal Article
  13. 13

    Pharmacology, pharmacokinetics and clinical development of haloperidol decanoate by Gelders, Y G

    Published in International clinical psychopharmacology (01-07-1986)
    “…The absorption mechanism of haloperidol decanoate from the intramuscular depot was studied in dogs. Haloperidol, a pharmacologically active molecule…”
    Get more information
    Journal Article
  14. 14
  15. 15

    12-month study of haloperidol decanoate in chronic schizophrenic patients by Gelders, Y G, Reyntijens, A J, Ash, C W, Aerts, T J

    Published in International pharmacopsychiatry (1982)
    “…239 psychotic patients entered a 52-week open study comparing the efficacy and safety of intramuscular haloperidol decanoate, injected once every 4 weeks, with…”
    Get more information
    Journal Article
  16. 16

    Pharmacokinetics of haloperidol decanoate. A 2-year follow-up by Reyntigens, A J, Heykants, J J, Woestenborghs, R J, Gelders, Y G, Aerts, T J

    Published in International pharmacopsychiatry (1982)
    “…Plasma haloperidol levels were assayed in 181 chronic schizophrenic inpatients, who were monthly injected intramuscularly with haloperidol decanoate. Steady…”
    Get more information
    Journal Article
  17. 17

    Milenperone. A selective drug for the control of behavioral disorders in epileptic and alcoholic patients by Gelders, Y G, Reyntjens, A J, Aerts, T J

    Published in Acta psychiatrica Belgica (01-03-1984)
    “…Thirty-four patients took part in an 8-week open investigation aimed at evaluating the efficacy of low oral doses of milenperone as non-sedative neuroleptic…”
    Get more information
    Journal Article
  18. 18

    Development of new antipsychotic drugs by Vanden Bussche, G, Gelders, Y G, Heylen, S L

    “…As far as schizophrenia is concerned, therapeutical effects of neuroleptics based on brain-located dopamine receptor blockers are taken for granted. It is also…”
    Get more information
    Journal Article
  19. 19